|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 5/00 | |
| C07J 7/00 | |||
| C07J 31/00 | |||
| C07J 43/00 | |||
| A61K 31/57 | |||
| A61K 31/573 | |||
| A61K 31/58 | |||
| A61P 25/00 |
| (11) | Number of the document | 2766380 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12781534.8 |
| Date of filing the European patent application | 2012-10-12 | |
| (97) | Date of publication of the European application | 2014-08-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/060136 |
| Date | 2012-10-12 |
| (87) | Number | WO 2013/056181 |
| Date | 2013-04-18 |
| (30) | Number | Date | Country code |
| 201161547291 P | 2011-10-14 | US | |
| 201261698204 P | 2012-09-07 | US |
| (72) |
UPASANI, Ravindra, B., US
ASKEW, Benny, C., US
HARRISON, Boyd, L., US
SALITURO, Francesco, G., US
ROBICHAUD, Albert, J., US
|
| (73) |
Sage Therapeutics, Inc.,
215 First Street, Cambridge, MA 02142,
US
|
| (54) | 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF |
| 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF |